Chemomab Therapeutics

-$0.16 (-4.03%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CMMB and other ETFs, options, and stocks.

About CMMB

Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. It discovers and develops therapeutics for conditions with unmet need that involve Inflammation and fibrosis.

CEO
Dale R. Pfost
Employees
—
Headquarters
Tel Aviv, Tel Aviv
Founded
2011

CMMB Key Statistics

Market cap
44.87M
Price-Earnings ratio
—
Dividend yield
—
Average volume
61.14K
High today
$4.13
Low today
$3.77
Open price
$3.98
Volume
61.49K
52 Week high
$20.96
52 Week low
$2.53

CMMB Earnings

-$0.44
-$0.29
-$0.15
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure